Get started
Author

Dong‐Kun Zhao

Observed name: Dong-Kun Zhao
OpenAlex ID: A5045933736
Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
2021 · Cheng-Tao Jiang, Kai-Ge Chen, et al. · Nature Communications · 117
PDF
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity
2024 · Qian-Ni Ye, Long Zhu, et al. · Nature Communications · 59
PDF
A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer
2021 · Qi‐Song Tong, Wei‐Min Miao, et al. · Small · 43
Engineering multi-specific nano-antibodies for cancer immunotherapy
2025 · Ya-Nan Fan, Long Zhu, et al. · Nature Biomedical Engineering · 27
Organoids technology for advancing the clinical translation of cancer nanomedicine
2023 · Dong‐Kun Zhao, Jie Liang, et al. · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 25
Dual-functional super bispecific nano-antibodies derived from monoclonal antibodies potentiate the antitumor effect of innate immune cells
2021 · Kai-Ge Chen, An Liu, et al. · Nano Today · 17
Combinatorial screening of nanomedicines in patient-derived cancer organoids facilitates efficient cancer therapy
2025 · Jie Liang, Dong-Kun Zhao, et al. · Nano Today · 10
Receptor-Modular Nanocaptors for Programmable Cytokine Sequestration
2026 · Yin-Yi Cai, Dong-Kun Zhao, et al. · ACS Nano
Activation-optimized anti-CD3 valency control enables combinatorial discovery of multi-specific nanoantibodies for solid tumor immunotherapy
2026 · Long Zhu, Ya-Jing Ma, et al. · 中国科学通报：英文版
A genetically programmable, conjugation-free nanomedicine platform for modular antibody-guided drug delivery
2026 · Tai-Yu Tian, Dong-Kun Zhao, et al. · Cell Biomaterials
A dual-tumor-recognition trispecific T-cell nano-engager enhances effector–target conjugation and antitumor activity
2026 · Ya-Jing Ma, Zheng Zhang, et al. · Biomaterials Science
Works count: 11
Citation count: 298
H-index: 7
I10-index: 7
Year
Topic
Type